Nonchimeric HLA-identical renal transplant tolerance: Regulatory immunophenotypic/genomic biomarkers

American Journal of Transplantation

Volumn 16, Issue 1, 2016, Pages 221-234

  Leventhal, J R ^a   Mathew, J M ^a,b   Salomon, D R ^c   Kurian, S M ^c   Friedewald, J J ^a   Gallon, L ^a   Konieczna, I ^a   Tambur, A R ^a   Charette, J ^a   Levitsky, J ^a   Jie, C ^a   Kanwar, Y S ^b   Abecassis, M M ^a,b   Miller, J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BIOLOGICAL MARKER; CD28 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPHRIN; FATTY ACID; FOCAL ADHESION KINASE; GLUTAMINE; GLYCEROL; INDUCIBLE T CELL COSTIMULATOR; INTEGRIN; INTEGRIN LINKED KINASE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; RANTES; RNA; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3; VASCULOTROPIN; HLA ANTIGEN;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD GROUP TYPING; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL PROTOCOL; CREATININE CLEARANCE; DISEASE COURSE; DOWN REGULATION; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MAPPING; GENOMICS; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIPOGENESIS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREATIC NEUROENDOCRINE TUMOR; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEINURIA; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TRANSPLANTATION TOLERANCE; UNINDEXED SEQUENCE; UPREGULATION; YOUNG ADULT; GENETICS; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BIOMARKERS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENOMICS; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; IMMUNOPHENOTYPING; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE;

EID: 84956917318     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13416     Document Type: Article

References (31)

1. Seigler HF, Gunnells JC Jr., Robinson RR, et al., Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation. J Clin Invest 1972; 51: 3200-3215.
2. Gerrits JH, van de Wetering J, Weimar W, van Besouw NM,. T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients. Transplantation 2009; 87: 907-914.
3. van de Wetering J, Gerrits JH, van Besouw NM, Ijzermans JNM, Weimar W,. Successful tapering of immunosuppression to low-dose monotherapy steroids after living-related human leukocyte antigen-identical renal transplantation. Transplantation 2009; 87: 740-744.
4. Spitzer TR, Delmonico F, Tolkoff-Rubin N, et al., Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999; 68: 480-484.
5. Scandling JD, Busque S, Dejbakhsh-Jones S, et al., Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008; 358: 362-368.
6. Scandling JD, Busque S, Dejbakhsh-Jones S, et al., Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant 2012; 12: 1133-1145.
7. Scandling JD, Busque S, Shizuru JA, et al., Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation. Am J Transplant 2015; 15: 695-704.
8. Kawai T, Cosimi AB, Spitzer TR, et al., HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353-361.
9. Leventhal J, Abecassis M, Miller J, et al., Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 2012; 4: 124ra28.
10. Leventhal JR, Mathew JM, Salomon DR, et al., Genomic biomarkers correlate with HLA-identical renal transplant tolerance. J Am Soc Nephrol 2013; 24: 1376-1385.
11. Leventhal J, Abecassis M, Miller J, et al., Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: Durable chimerism predicts outcome. Transplantation 2013; 95: 169-176.
12. Shinoda K, Akiyoshi T, Chase CM, et al., Depletion of Foxp3+ T cells abrogates tolerance of skin and heart allografts in murine mixed chimeras without the loss of mixed chimerism. Am J Transplant 2014; 14: 2263-2274.
13. Cobbold SP, Nolan KF, Graca L, et al., Regulatory T cells and dendritic cells in transplantation tolerance: Molecular markers and mechanisms. Immunol Rev 2003; 196: 109-124.
14. Brouard S, Mansfield E, Braud C, et al., Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007; 104: 15448-15453.
15. Newell KA, Asare A, Kirk AD, et al., Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010; 120: 1836-1847.
16. Verghese PS, Dunn TB, Chinnakotla S, Gillingham KJ, Matas AJ, Mauer MS,. Calcineurin inhibitors in HLA-identical living related donor kidney transplantation. Nephrol Dial Transplant 2014; 29: 209-218.
17. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M,. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
18. Wolf D, Wolf AM, Fong D, et al., Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation. Transplantation 2007; 83: 1107-1113.
19. Mathew JM, Ciancio G, Burke GW, et al., Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assays. Hum Immunol 2010; 71: 566-576.
20. Shaffer J, Villard J, Means TK, et al., Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. Exp Hematol 2007; 35: 1140-1152.
21. LoCascio SA, Morokata T, Chittenden M, et al., Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation 2010; 90: 1607-1615.
22. Mathew JM, Garcia-Morales R, Fuller L, et al., Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses. Transplantation 2000; 70: 1675-1682.
23. Cirocco RE, Carreno MR, Mathew JM, et al., FoxP3 mRNA transcripts and regulatory cells in renal transplant recipients 10 years after donor marrow infusion. Transplantation 2007; 83: 1611-1619.
24. Mathew JM, Carreno M, Zucker K, et al., Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation. Transplantation 1998; 65: 947-955.
25. Mathew JM, Fuller L, Carreno M, et al., Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses. Transplantation 2000; 70: 1752-1760.
26. Mathew JM, Garcia-Morales RO, Carreno M, et al., Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation. Transpl Immunol 2003; 11: 307-321.
27. Dickinson AM, Wang X-N, Sviland L, et al., In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med 2002; 8: 410-414.
28. Burlingham WJ, Goulmy E,. Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens. Hum Immunol 2008; 69: 728-731.
29. Levitsky J, Miller J, Leventhal J, et al., The human "Treg MLR": Immune monitoring for FOXP3+ T regulatory cell generation. Transplantation 2009; 88: 1303-1311.
30. Pidala J, Bloom GC, Eschrich S, et al., Tolerance associated gene expression following allogeneic hematopoietic cell transplantation. PLoS ONE 2015; 10: e0117001.
31. Emerson RO, Mathew JM, Konieczna IM, Robins HS, Leventhal JR,. Defining the alloreactive T cell repertoire using high-throughput sequencing of mixed lymphocyte reaction culture. PLoS ONE 2014; 9: e111943.